Abstract
Prior literature indicates long-acting injectable (LAI) antipsychotics (APs) have advantages over oral APs, including higher adherence rates and lower healthcare resource utilization. However, comparisons among individual LAI second generation antipsychotics (SGAs) have resulted in mixed findings since many studies did not adjust for confounders. This retrospective cohort study compared adherence for enrollees with schizophrenia by LAI SGA medication.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
